enVVeno Medical Corporation (NVNO)
USD 2.26
(-9.07%)
USD 2.26
(-9.07%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.21 Million USD | 21.87% |
| 2022 | -2.83 Million USD | 94.62% |
| 2021 | -52.72 Million USD | -523.64% |
| 2020 | -8.45 Million USD | -1776.16% |
| 2019 | -450.59 Thousand USD | 83.56% |
| 2018 | -2.74 Million USD | -207.85% |
| 2017 | 2.54 Million USD | 340.98% |
| 2016 | 576.25 Thousand USD | 134.53% |
| 2015 | 245.7 Thousand USD | -75.67% |
| 2014 | 1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -16.76 Million USD | -1361.81% |
| 2024 Q2 | -1.14 Million USD | -15.05% |
| 2024 Q1 | -997 Thousand USD | 55.05% |
| 2023 Q1 | -636 Thousand USD | 77.6% |
| 2023 FY | -2.21 Million USD | 21.87% |
| 2023 Q3 | -3.46 Million USD | -9.89% |
| 2023 Q4 | -2.21 Million USD | 36.03% |
| 2023 Q2 | -3.15 Million USD | -396.07% |
| 2022 Q1 | -49.4 Million USD | 6.29% |
| 2022 Q3 | -1.1 Million USD | 84.66% |
| 2022 Q4 | -2.83 Million USD | -156.69% |
| 2022 Q2 | -7.2 Million USD | 85.41% |
| 2022 FY | -2.83 Million USD | 94.62% |
| 2021 Q2 | -40.31 Million USD | 6.32% |
| 2021 Q1 | -43.03 Million USD | -409.05% |
| 2021 FY | -52.72 Million USD | -523.64% |
| 2021 Q4 | -52.72 Million USD | 8.41% |
| 2021 Q3 | -57.56 Million USD | -42.78% |
| 2020 Q2 | -538.93 Thousand USD | -867.8% |
| 2020 Q1 | 70.19 Thousand USD | 115.58% |
| 2020 Q3 | -4.67 Million USD | -767.67% |
| 2020 FY | -8.45 Million USD | -1776.16% |
| 2020 Q4 | -8.45 Million USD | -80.79% |
| 2019 Q4 | -450.59 Thousand USD | 77.7% |
| 2019 FY | -450.59 Thousand USD | 83.56% |
| 2019 Q3 | -2.02 Million USD | 41.88% |
| 2019 Q2 | -3.47 Million USD | -104.84% |
| 2019 Q1 | -1.69 Million USD | 38.08% |
| 2018 Q3 | -4.18 Million USD | 29.5% |
| 2018 Q4 | -2.74 Million USD | 34.58% |
| 2018 FY | -2.74 Million USD | -207.85% |
| 2018 Q1 | 4.38 Million USD | 72.68% |
| 2018 Q2 | -5.94 Million USD | -235.42% |
| 2017 FY | 2.54 Million USD | 340.98% |
| 2017 Q2 | 1.02 Million USD | 1709.51% |
| 2017 Q1 | 56.51 Thousand USD | -90.19% |
| 2017 Q3 | 1.35 Million USD | 32.77% |
| 2017 Q4 | 2.54 Million USD | 87.16% |
| 2016 FY | 576.25 Thousand USD | 134.53% |
| 2016 Q4 | 576.25 Thousand USD | 57.14% |
| 2016 Q3 | 366.72 Thousand USD | 0.0% |
| 2016 Q1 | 1.58 Million USD | 545.17% |
| 2015 FY | 245.7 Thousand USD | -75.67% |
| 2015 Q4 | 245.7 Thousand USD | 0.0% |
| 2014 FY | 1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 108.19% |
| BrainsWay Ltd. | -10.32 Million USD | 78.508% |
| Cerus Corporation | 84.35 Million USD | 102.629% |
| Envoy Medical, Inc. | -3.81 Million USD | 41.846% |
| electroCore, Inc. | -9.95 Million USD | 77.72% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 56.722% |
| IceCure Medical Ltd | -9.93 Million USD | 77.673% |
| Inogen, Inc. | -103.56 Million USD | 97.858% |
| OrthoPediatrics Corp. | -9.26 Million USD | 76.066% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 39.083% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 83.065% |
| MaxCyte, Inc. | -27.76 Million USD | 92.011% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 56.832% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -285.225% |
| Orthofix Medical Inc. | 96.44 Million USD | 102.3% |
| PAVmed Inc | 29.08 Million USD | 107.626% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 86.906% |
| RxSight, Inc. | -6.68 Million USD | 66.796% |
| Sight Sciences, Inc. | -102.71 Million USD | 97.841% |
| SI-BONE, Inc. | 5.72 Million USD | 138.769% |
| TELA Bio, Inc. | -3.94 Million USD | 43.834% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 103.869% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 730.114% |
| Acutus Medical, Inc. | 12.27 Million USD | 118.063% |
| Talis Biomedical Corporation | -57.06 Million USD | 96.113% |
| Spectral AI, Inc. | -3.5 Million USD | 36.647% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 95.382% |
| CVRx, Inc. | -59.95 Million USD | 96.301% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 211.786% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 273.602% |
| Bioventus Inc. | 372.51 Million USD | 100.595% |
| Venus Concept Inc. | 74.3 Million USD | 102.985% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 78.216% |
| LivaNova PLC | 62.53 Million USD | 103.547% |
| 908 Devices Inc. | -115.09 Million USD | 98.073% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 100.692% |
| Nemaura Medical Inc. | 9.92 Million USD | 122.348% |
| NeuroPace, Inc. | 54.33 Million USD | 104.082% |
| LENSAR, Inc. | -18.31 Million USD | 87.888% |
| Apyx Medical Corporation | -5.15 Million USD | 56.94% |
| Cutera, Inc. | 288.3 Million USD | 100.769% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 129.514% |
| BioSig Technologies, Inc. | 262 Thousand USD | 946.565% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 94.94% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 75.889% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.158% |
| Axonics, Inc. | -77.19 Million USD | 97.127% |
| Outset Medical, Inc. | 67.67 Million USD | 103.277% |
| IRIDEX Corporation | -4.28 Million USD | 48.274% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 98.754% |
| IRadimed Corporation | -47.71 Million USD | 95.352% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 26.702% |
| INVO Bioscience, Inc. | 8.45 Million USD | 126.245% |
| Telesis Bio, Inc. | 32.63 Million USD | 106.796% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 11.356% |
| Varex Imaging Corporation | 316.9 Million USD | 100.7% |
| Quipt Home Medical Corp. | 81.73 Million USD | 102.714% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 20.273% |
| Pulmonx Corporation | -42.36 Million USD | 94.764% |
| Dynatronics Corporation | 6.2 Million USD | 135.751% |
| Modular Medical, Inc. | -8.04 Million USD | 72.42% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 48.383% |
| Semler Scientific, Inc. | -57.13 Million USD | 96.118% |
| InMode Ltd. | -135.39 Million USD | 98.362% |
| Bruker Corporation | 891.3 Million USD | 100.249% |
| Cytosorbents Corporation | 4.18 Million USD | 153.037% |
| DexCom, Inc. | 2.02 Billion USD | 100.109% |
| Align Technology, Inc. | -840.47 Million USD | 99.736% |
| Viveve Medical, Inc. | -13.81 Million USD | 83.943% |
| ZimVie Inc. | 450.41 Million USD | 100.492% |
| Movano Inc. | -5.86 Million USD | 62.189% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 98.35% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -285.225% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 211.786% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 100.622% |
| Profound Medical Corp. | -18.17 Million USD | 87.799% |
| Insulet Corporation | 798.1 Million USD | 100.278% |
| Surmodics, Inc. | -12.01 Million USD | 81.538% |
| iCAD, Inc. | -21.2 Million USD | 89.542% |
| Nuwellis, Inc. | -2.81 Million USD | 21.32% |
| Biotricity, Inc. | 23.09 Million USD | 109.605% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 102.368% |
| Aethlon Medical, Inc. | -4.5 Million USD | 50.729% |
| InspireMD, Inc. | -8.04 Million USD | 72.43% |
| PAVmed Inc. | 29.08 Million USD | 107.626% |
| BIOLASE, Inc. | 11.34 Million USD | 119.552% |
| Beyond Air, Inc. | 6.22 Million USD | 135.608% |
| FONAR Corporation | -14.66 Million USD | 84.876% |
| AxoGen, Inc. | 32.26 Million USD | 106.874% |
| Vivani Medical, Inc. | 42 Thousand USD | 5380.952% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 79.189% |
| Inari Medical, Inc. | -7.16 Million USD | 69.027% |
| UFP Technologies, Inc. | 40.77 Million USD | 105.44% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 172.28% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 53.514% |
| Tenon Medical, Inc. | -1.25 Million USD | -76.733% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 70.839% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 81.402% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.1% |
| Sintx Technologies, Inc. | 905 Thousand USD | 345.083% |
| NanoVibronix, Inc. | -3.27 Million USD | 32.337% |
| Quanterix Corporation | -132.95 Million USD | 98.332% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 20.273% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 90.083% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.294% |
| TransMedics Group, Inc. | 121.13 Million USD | 101.831% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 91.528% |
| NeuroMetrix, Inc. | -1.49 Million USD | -48.752% |
| Hyperfine, Inc. | -75.61 Million USD | 97.067% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 101.457% |
| Biomerica, Inc. | -3.38 Million USD | 34.476% |
| Bone Biologics Corporation | -3.02 Million USD | 26.716% |
| AVITA Medical, Inc. | -26.23 Million USD | 91.545% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -20.648% |
| Silk Road Medical, Inc | 64.42 Million USD | 103.443% |